Woxmen Bio Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Woxmen Bio Technologies
Woxmen Bio Technologies Private Limited (WBTPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 November 2013 and has a history of 11 years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dinkar Sharma, Mahipal Mukku, Mrinal, and One other member serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100PN2013PTC149333
-
Company No.
149333
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Nov 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Woxmen Bio Technologies Private Limited offer?
Woxmen Bio Technologies Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Woxmen Bio Technologies?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shardul Yadav
|
Director | 29-Jul-2016 | Current |
|
Dinkar Sharma
|
Director | 01-Nov-2013 | Current |
|
Mahipal Mukku
|
Director | 01-Nov-2013 | Current |
|
Mrinal
|
Director | 29-Jul-2016 | Current |
Financial Performance of Woxmen Bio Technologies.
Woxmen Bio Technologies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Woxmen Bio Technologies?
In 2017, Woxmen Bio Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Woxmen LlpDinkar Sharma is a mutual person
-
Kosmyq Scientific LlpDinkar Sharma is a mutual person
-
Fourier & George Scientific India Private Limited
Shardul Yadav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Woxmen Bio Technologies?
Unlock and access historical data on people associated with Woxmen Bio Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Woxmen Bio Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Woxmen Bio Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.